William H. Sano

William H. Sano

Auto-generated profile, based on publicly available information

William H. Sano

Department of Molecular Microbiology and Immunology, Division of Biology and Medicine, Brown University, Providence, RI, 02912, USA

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 May 2018 in Foods
Verified
Journal Article
Open access
PDF file
MZMichelle Zabat
Michelle Zabat
WSWilliam H. Sano
William H. Sano
JWJenna Wurster
Jenna Wurster
DCDamien Cabral
Damien Cabral
PBPeter Belenky
Peter Belenky
Despite recent interest in microbial communities of fermented foods, there has been little inquiry into the bacterial community dynamics of sauerkraut, one of the world’s oldest and most prevalent fermented foods. In this study, we utilize 16S rRNA amplicon sequencing to profile the microbial community of naturally fermented sauerkraut throughout the fermentation process while also analyzing the bacterial communities of the starting ingredients and the production environment. Our results indicate that the sauerkraut microbiome is rapidly established after fermentation begins and that the community is stable through fermentation and packaging for commercial sale. Our high-throughput analysis is in agreement with previous studies that utilized traditional microbiological assessments but expands the identified taxonomy. Additionally, we find that the microbial communities of the starting ingredients and the production facility environment exhibit low relative abundance of the lactic acid bacteria that dominate fermented sauerkraut.

1 September 2018 in Food Microbiology
Verified
Journal Article
Closed access
MZMichelle Zabat
Michelle Zabat
WSWilliam H. Sano
William H. Sano
DCDamien Cabral
Damien Cabral
JWJenna Wurster
Jenna Wurster
PBPeter Belenky
Peter Belenky

8 September 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
DCDamien Cabral
Damien Cabral
JWJenna Wurster
Jenna Wurster
MFMyrto E. Flokas
Myrto E. Flokas
MAMichail Alevizakos
Michail Alevizakos
MZMichelle Zabat
Michelle Zabat
PBPeter Belenky
Peter Belenky
In recent years, a growing amount of research has begun to focus on the oral microbiome due to its links with health and systemic disease. The oral microbiome has numerous advantages that make it particularly useful for clinical studies, including non-invasive collection, temporal stability, and lower complexity relative to other niches, such as the gut. Despite recent discoveries made in this area, it is unknown how the oral microbiome responds to short-term hospitalization. Previous studies have demonstrated that the gut microbiome is extremely sensitive to short-term hospitalization and that these changes are associated with significant morbidity and mortality. Here, we present a comprehensive pipeline for reliable bedside collection, sequencing, and analysis of the human salivary microbiome. We also develop a novel oral-specific mock community for pipeline validation. Using our methodology, we analyzed the salivary microbiomes of patients before and during hospitalization or azithromycin treatment to profile impacts on this community. Our findings indicate that azithromycin alters the diversity and taxonomic composition of the salivary microbiome; however, we also found that short-term hospitalization does not impact the richness or structure of this community, suggesting that the oral cavity may be less susceptible to dysbiosis during short-term hospitalization.

1 December 2021 in Cell Reports
Verified
Journal Article
Open access
JWJenna I. Wurster
Jenna I. Wurster
RPRachel Lynn Peterson
Rachel Lynn Peterson
CBClaire E. Brown
Claire E. Brown
SPSwathi Penumutchu
Swathi Penumutchu
DGDouglas V. Guzior
Douglas V. Guzior
PBPeter Belenky
Peter Belenky
It is well established in the microbiome field that antibiotic (ATB) use and metabolic disease both impact the structure and function of the gut microbiome. But how host and microbial metabolism interacts with ATB susceptibility to affect the resulting dysbiosis remains poorly understood. In a streptozotocin-induced model of hyperglycemia (HG), we use a combined metagenomic, metatranscriptomic, and metabolomic approach to profile changes in microbiome taxonomic composition, transcriptional activity, and metabolite abundance both pre- and post-ATB challenge. We find that HG impacts both microbiome structure and metabolism, ultimately increasing susceptibility to amoxicillin. HG exacerbates drug-induced dysbiosis and increases both phosphotransferase system activity and energy catabolism compared to controls. Finally, HG and ATB co-treatment increases pathogen susceptibility and reduces survival in a Salmonella enterica infection model. Our data demonstrate that induced HG is sufficient to modify the cecal metabolite pool, worsen the severity of ATB dysbiosis, and decrease colonization resistance.